Início
Mercados
Gráficos e ideias
Algo
Notícias
Market
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Heatmap
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
PLSE
#2259
Pulse Biosciences, Inc Common Stock (DE)
20.120
0
USD
+6.34%
Setor:
Cuidados de saúde
Base:
USD
Moeda do lucro:
USD
Faixa diária
Faixa anual
Mudança diária
+6.34%
Mudança mensal
-6.72%
Mudança em 6 meses
+10.85%
Mudança anual
+10.85%
Fechamento anterior
18.920
0
Abrir
20.120
0
Bid
Ask
Mínimo
20.120
0
High
20.120
0
Volume
57
Mercados
Ações
Cuidados de saúde
PLSE
Abrir gráfico completo
Financials
Visão geral
Relatórios
Estatísticas
Trimestral
Ano
Valor
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
26.09 M
29.8 M
37.59 M
55.23 M
67.27 M
67.99 M
—
Valuation ratios
Enterprise value
609.97 M
424.01 M
52.28 M
573.36 M
1.05 B
852.76 M
3.83 B
Price to earnings ratio
—
—
-1.6
-12.54
-18.97
-12.71
-58.35
Price to sales ratio
—
—
133.32
—
—
2 643.82
—
Price to cash flow ratio
—
—
-1.99
-16.02
-27.98
-17.1
-87.29
Price to book ratio
—
—
-41.51
11.93
8.85
11.47
19.35
Enterprise value to EBITDA ratio
-12.36
-12.18
-1.16
-37.07
-19.12
-11.14
-68.7
Profitability ratios
Return on assets %
-1.21
-1.17
-0.75
-0.71
-0.4
-0.77
-0.65
Return on equity %
-2.18
-1.78
26.03
-0.95
-0.47
-0.9
-0.75
Return on invested capital %
-761.9
-1 240.68
-1 276.4
-1 075.01
-1 538.65
-2 275.12
—
Gross margin %
—
-38.79
-1 606.29
—
—
-54
—
Operating margin %
—
-4 443.86
-8 293.86
—
—
-21.98 K
—
EBITDA margin %
—
-2 390.27
-5 191.86
—
—
-21.87 K
—
Net margin %
—
-4 489.42
-8 357.86
—
—
-20.79 K
—
Liquidity ratios
Quick ratio
—
3.62
10.39
—
—
10.51
48.14
Current ratio
2.95
4.3
10.39
6.76
11.88
10.53
48.17
Inventory turnover
—
0.1
2.91
—
—
—
—
Asset turnover
0
0.03
0.01
0
0
0
0
Solvency ratios
Debt to assets ratio
—
0.21
0.13
0.15
—
—
—
Debt to equity ratio
—
0.32
-4.47
0.21
—
—
—
Long term debt to total assets ratio
—
0.01
0
0
—
—
—
Long term debt to total equity ratio
—
0.01
0
0
—
—
—
Per share metrics
Operating cash flow per share
—
—
-1.39
-0.69
-0.62
-0.8
-0.8
EBIT per share
—
—
-1.71
-0.91
-0.96
-1.14
-1.14
EBITDA per share
—
—
-1.07
-0.32
-0.94
-1.14
-0.79
Total debt per share
—
—
0.3
0.19
—
—
—
Cash per share
—
—
1.8
0.92
2.02
1.2
5.97
Net current asset value per share
—
—
1.83
0.94
2.05
1.24
6.09
Tangible book value per share
—
—
0.01
0.99
2.03
1.27
6.15
Working capital per share
—
—
1.66
0.8
1.87
1.12
5.58
Book value per share
—
—
-0.07
0.92
1.97
1.2
5.89
Notícias
Pulse Biosciences Initiates Patient Enrollment in NANOPULSE-AF Study
Pulse Biosciences inicia estudo pivotal sobre fibrilação atrial
PLSE Accelerates Cardiac Catheter Program After Breakthrough AFib Data
Pulse Biosciences na conferência da Oppenheimer: resultados promissores na ablação de FA
Pulse Biosciences redireciona foco para programa de cateter cardíaco
Pulse Biosciences shifts focus to cardiac catheter program
Pulse Biosciences inscreve primeiros pacientes em estudo sobre câncer de tireoide
Pulse Biosciences enrolls first patients in thyroid cancer study
Diretor comercial da Pulse Biosciences renuncia com efeito imediato
Pulse Biosciences chief commercial officer resigns effective immediately
CCO da Pulse Biosciences vende US$ 118 mil em ações da PLSE
Pulse Biosciences CCO Danahy sells $118k in PLSE stock